首页> 外文期刊>Bone marrow transplantation >Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation.
【24h】

Histological improvement with lamivudine therapy for de novo hepatitis B occurring in an anti-HBs-positive child after bone marrow transplantation.

机译:拉米夫定治疗新生HBV的组织学改善,发生在骨髓移植后的抗HBs阳性儿童中。

获取原文
获取原文并翻译 | 示例
       

摘要

We describe a 14-year-old bone marrow transplant recipient who was anti-HBs-positive before the procedure and afterwards developed acute infection with hepatitis B virus (HBV). Liver biopsies taken while symptomatic showed portal fibrosis progressing to cirrhosis. The patient responded to lamivudine treatment with HBeAg seroconversion and significant regression of fibrosis. Although the source and timing of HBV exposure remain unclear, the potential for severe hepatitis B infection following bone marrow transplant warrants caution. This case demonstrates that a symptomatic HBV infection can occur in an immunocompromised patient who had originally been anti-HBs-positive.
机译:我们描述了一个14岁的骨髓移植受者,该接受者在手术前抗HBs阳性,之后发展为乙型肝炎病毒(HBV)急性感染。有症状的情况下进行的肝活检显示门脉纤维化进展为肝硬化。该患者对拉米夫定的HBeAg血清转换和纤维化明显消退有反应。尽管尚不清楚HBV暴露的来源和时间,但是在骨髓移植后发生严重B型肝炎的可能性值得谨慎。该病例表明,原本是抗HBs阳性的免疫功能低下的患者可能会出现症状性HBV感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号